Your browser doesn't support javascript.
loading
Positively increased visceral adiposity index in hyperuricemia free of metabolic syndrome.
Gu, Dongfeng; Ding, Yanan; Zhao, Yunfeng; Miao, Shuzhai; Qu, Qingshan.
Afiliación
  • Gu D; Department of Nephrology and Transplantation Center, The People's Hospital of Zhengzhou, Affiliated with Southern Medical University, Zhengzhou, 450003, People's Republic of China. dongfenggu@hotmail.com.
  • Ding Y; Division of Cardiovascular Medicine, The People's Hospital of Zhengzhou, Affiliated with Southern Medical University, Zhengzhou, 450003, People's Republic of China.
  • Zhao Y; Department of Nephrology and Transplantation Center, The People's Hospital of Zhengzhou, Affiliated with Southern Medical University, Zhengzhou, 450003, People's Republic of China.
  • Miao S; Department of Nephrology and Transplantation Center, The People's Hospital of Zhengzhou, Affiliated with Southern Medical University, Zhengzhou, 450003, People's Republic of China.
  • Qu Q; Department of Nephrology and Transplantation Center, The People's Hospital of Zhengzhou, Affiliated with Southern Medical University, Zhengzhou, 450003, People's Republic of China.
Lipids Health Dis ; 17(1): 101, 2018 May 07.
Article en En | MEDLINE | ID: mdl-29734946
ABSTRACT

BACKGROUND:

Visceral adiposity index (VAI) was closely associated with metabolic syndrome, however almost no research focused on VAI and hyperuricemia, therefore, this study was conducted to determine the relationship of VAI and hyperuricemia free of metabolic syndrome and estimate the power of VAI as predictor for hyperuricemia.

METHODS:

A cross-sectional research coming from a health check-up program was conducted. All participants were divided into four groups according to VAI quartiles. A multivariate logistic analysis was used to analyze the relationship between the quartiles and hyperuricemia. A receiver operating characteristic (ROC) curve analysis was used to evaluate the accuracy of predictions for hyperuricemia.

RESULTS:

VAI was independent risk factor of hyperuricemia. The ORs of which in the upper quartile were 3.077 (95%CI 1.78-5.293), P = 0.000, in model 1, after adjusting for age, systolic blood pressure, diastolic blood pressure, heart rate, fast plasma glucose, serum creatinine, triglyceride, total cholesterol, high density lipoprotein cholesterol, and low density lipoprotein cholesterol; and 3.041 (95CI 1.767-5.233), P = 0.000, in model 2, after adjusting for the above plus physical activity, diet, smoking habits, alcohol consumption, hypertension and diabetes history. The area under the ROC curve (AUC) value of VAI was 0.618 (95%CI 0.572-0.665), P = 0.000; it was higher than WC, which was 0.556 (95%CI 0.508-0.604), P = 0.024, for hyperuricemia.

CONCLUSIONS:

VAI was associated with hyperuricemia among individuals free of metabolic syndrome, and also a powerful indicator.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hiperuricemia / Diabetes Mellitus / Grasa Intraabdominal / Obesidad Abdominal Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lipids Health Dis Asunto de la revista: BIOQUIMICA / METABOLISMO Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hiperuricemia / Diabetes Mellitus / Grasa Intraabdominal / Obesidad Abdominal Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lipids Health Dis Asunto de la revista: BIOQUIMICA / METABOLISMO Año: 2018 Tipo del documento: Article